<DOC>
	<DOCNO>NCT02811185</DOCNO>
	<brief_summary>This single-centre , open-label , non-randomized clinical trial design monitor occurrence adverse event associate [ F-18 ] -FDG Injection manufacture Fedoruk Centre . [ F-18 ] -FDG Injection use clinical trial identical commercial [ F-18 ] -FDG already use Royal University Hospital ( RUH ) .</brief_summary>
	<brief_title>Registry Type Study Monitor Adverse Drug Reactions Fedoruk Manufactured F-18-Fludeoxyglucose</brief_title>
	<detailed_description>This study document use Fedoruk-manufactured [ F-18 ] -FDG Injection ( citrate formulation ) patient refer [ F-18 ] -FDG PET PET/CT image Royal University Hospital ( RUH ) Saskatoon , SK . This investigational agent produce use procedure , raw material , equipment quality standard equivalent commercially-approved [ F-18 ] -FDG Injection ( Glucovision® , manufacture CPDC Hamilton ON ) . This single-centre , open-label , non-randomized study monitor adverse drug reaction among subject administer Fedoruk-manufactured [ F-18 ] -FDG Injection . Eligible subject would normally refer physician [ F-18 ] -FDG PET PET/CT image RUH Saskatoon , SK . The primary goal study permit immediate access , appropriate regulatory REB oversight , Fedoruk-manufactured [ F-18 ] -FDG Injection pending commercial approval . Monitoring adverse drug reaction , subject administer Fedoruk-manufactured [ F-18 ] -FDG Injection , support primary objective study . Based well-established safety profile [ F-18 ] -FDG comparability Fedoruk-manufactured [ F-18 ] -FDG Injection commercially-approved [ F-18 ] -FDG Injection ( Glucovision® ) , expect ADRs observe .</detailed_description>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<criteria>Referred treat physician receive [ F18 ] FDG PET PET/CT imaging ; Meets current local clinical criterion receive [ F18 ] FDG PET PET/CT imaging ; Ability understand willingness sign , ( case paediatric patient ) parent/guardian understands willing sign , write informed consent document ; Pregnant woman ; woman childbearing potential confirm negative urine pregnancy test prior administration [ F18 ] FDG Injection ; Subjects unwilling unable stop breast feed 24 hour ; Subjects medically unstable , base Principal Investigator 's assessment</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>PET</keyword>
	<keyword>CT</keyword>
	<keyword>PET/CT</keyword>
</DOC>